WELIREGTM (belzutifan), FDA Approved, Available at Biologics by McKesson

CARY, N.C., August 20, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Merck& Co. as a specialty pharmacy provider for WELIREGTM (belzutifan), an inhibitor of hypoxia-inducible factor-2a (HIF-2a) indicated for the t...
Source: McKesson News - Category: Information Technology Source Type: news